nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ABCB1—ovarian cancer	0.21	1	CbGaD
Losartan—SLCO1B3—Paclitaxel—ovarian cancer	0.0973	0.196	CbGbCtD
Losartan—UGT2B7—Epirubicin—ovarian cancer	0.096	0.194	CbGbCtD
Losartan—SLCO1B3—Docetaxel—ovarian cancer	0.0703	0.142	CbGbCtD
Losartan—ABCB1—Topotecan—ovarian cancer	0.0328	0.0662	CbGbCtD
Losartan—CYP3A5—Paclitaxel—ovarian cancer	0.0249	0.0503	CbGbCtD
Losartan—CYP2C8—Paclitaxel—ovarian cancer	0.024	0.0484	CbGbCtD
Losartan—ABCB1—Vinorelbine—ovarian cancer	0.0231	0.0466	CbGbCtD
Losartan—CYP3A4—Topotecan—ovarian cancer	0.0196	0.0397	CbGbCtD
Losartan—CYP3A5—Docetaxel—ovarian cancer	0.018	0.0364	CbGbCtD
Losartan—CYP2C9—Paclitaxel—ovarian cancer	0.0167	0.0338	CbGbCtD
Losartan—ABCB1—Paclitaxel—ovarian cancer	0.0162	0.0328	CbGbCtD
Losartan—CYP3A4—Vinorelbine—ovarian cancer	0.0138	0.0279	CbGbCtD
Losartan—ABCB1—Docetaxel—ovarian cancer	0.0117	0.0237	CbGbCtD
Losartan—CYP3A4—Paclitaxel—ovarian cancer	0.00972	0.0196	CbGbCtD
Losartan—ABCB1—Doxorubicin—ovarian cancer	0.00875	0.0177	CbGbCtD
Losartan—UGT2B17—epithelium—ovarian cancer	0.00781	0.128	CbGeAlD
Losartan—CYP3A4—Docetaxel—ovarian cancer	0.00703	0.0142	CbGbCtD
Losartan—UGT2B17—endometrium—ovarian cancer	0.00701	0.114	CbGeAlD
Losartan—ACE—vein—ovarian cancer	0.00634	0.103	CbGeAlD
Losartan—CYP3A4—Doxorubicin—ovarian cancer	0.00524	0.0106	CbGbCtD
Losartan—SLC2A9—female reproductive system—ovarian cancer	0.00257	0.0419	CbGeAlD
Losartan—SLC2A9—female gonad—ovarian cancer	0.00234	0.0382	CbGeAlD
Losartan—SLC2A9—testis—ovarian cancer	0.00207	0.0338	CbGeAlD
Losartan—AGTR1—myometrium—ovarian cancer	0.00169	0.0276	CbGeAlD
Losartan—SLC2A9—lymph node—ovarian cancer	0.0015	0.0245	CbGeAlD
Losartan—SLCO1B3—vagina—ovarian cancer	0.00147	0.024	CbGeAlD
Losartan—UGT2B7—female reproductive system—ovarian cancer	0.00133	0.0217	CbGeAlD
Losartan—AGTR1—epithelium—ovarian cancer	0.00133	0.0216	CbGeAlD
Losartan—AGTR1—uterine cervix—ovarian cancer	0.00131	0.0214	CbGeAlD
Losartan—AGTR1—decidua—ovarian cancer	0.00125	0.0204	CbGeAlD
Losartan—ACE—embryo—ovarian cancer	0.0012	0.0196	CbGeAlD
Losartan—UGT2B7—testis—ovarian cancer	0.00107	0.0175	CbGeAlD
Losartan—AGTR1—female reproductive system—ovarian cancer	0.000985	0.0161	CbGeAlD
Losartan—ACE—epithelium—ovarian cancer	0.000979	0.016	CbGeAlD
Losartan—SLCO1B1—female reproductive system—ovarian cancer	0.000939	0.0153	CbGeAlD
Losartan—ACE—decidua—ovarian cancer	0.000925	0.0151	CbGeAlD
Losartan—AGTR1—vagina—ovarian cancer	0.000891	0.0145	CbGeAlD
Losartan—ACE—endometrium—ovarian cancer	0.000878	0.0143	CbGeAlD
Losartan—ACE—gonad—ovarian cancer	0.000814	0.0133	CbGeAlD
Losartan—AGTR1—testis—ovarian cancer	0.000795	0.013	CbGeAlD
Losartan—ACE—female reproductive system—ovarian cancer	0.000727	0.0119	CbGeAlD
Losartan—ACE—bone marrow—ovarian cancer	0.000686	0.0112	CbGeAlD
Losartan—ACE—female gonad—ovarian cancer	0.000662	0.0108	CbGeAlD
Losartan—CYP2C8—endometrium—ovarian cancer	0.000644	0.0105	CbGeAlD
Losartan—CYP3A5—uterine cervix—ovarian cancer	0.000643	0.0105	CbGeAlD
Losartan—ALB—testis—ovarian cancer	0.000613	0.01	CbGeAlD
Losartan—ACE—testis—ovarian cancer	0.000587	0.00958	CbGeAlD
Losartan—AGTR1—lymph node—ovarian cancer	0.000576	0.0094	CbGeAlD
Losartan—CYP2C19—vagina—ovarian cancer	0.000553	0.00903	CbGeAlD
Losartan—CYP2C8—female reproductive system—ovarian cancer	0.000534	0.00871	CbGeAlD
Losartan—CYP2C8—vagina—ovarian cancer	0.000483	0.00788	CbGeAlD
Losartan—CYP2C9—female reproductive system—ovarian cancer	0.000474	0.00774	CbGeAlD
Losartan—ALB—lymph node—ovarian cancer	0.000444	0.00725	CbGeAlD
Losartan—ABCB1—myometrium—ovarian cancer	0.000439	0.00716	CbGeAlD
Losartan—CYP3A5—female gonad—ovarian cancer	0.000438	0.00716	CbGeAlD
Losartan—CYP3A5—vagina—ovarian cancer	0.000436	0.00711	CbGeAlD
Losartan—CYP2C8—testis—ovarian cancer	0.000431	0.00703	CbGeAlD
Losartan—ACE—lymph node—ovarian cancer	0.000425	0.00694	CbGeAlD
Losartan—ABCB1—embryo—ovarian cancer	0.000422	0.00689	CbGeAlD
Losartan—CYP3A4—female reproductive system—ovarian cancer	0.000362	0.0059	CbGeAlD
Losartan—ABCB1—epithelium—ovarian cancer	0.000345	0.00562	CbGeAlD
Losartan—ABCB1—uterine cervix—ovarian cancer	0.000342	0.00558	CbGeAlD
Losartan—ABCB1—decidua—ovarian cancer	0.000325	0.00531	CbGeAlD
Losartan—ABCB1—endometrium—ovarian cancer	0.000309	0.00504	CbGeAlD
Losartan—ABCB1—gonad—ovarian cancer	0.000287	0.00468	CbGeAlD
Losartan—ABCB1—uterus—ovarian cancer	0.000285	0.00465	CbGeAlD
Losartan—ABCB1—female reproductive system—ovarian cancer	0.000256	0.00418	CbGeAlD
Losartan—ABCB1—bone marrow—ovarian cancer	0.000242	0.00394	CbGeAlD
Losartan—ABCB1—female gonad—ovarian cancer	0.000233	0.0038	CbGeAlD
Losartan—ABCB1—vagina—ovarian cancer	0.000231	0.00378	CbGeAlD
Losartan—ABCB1—testis—ovarian cancer	0.000207	0.00337	CbGeAlD
Losartan—Rash—Vinorelbine—ovarian cancer	0.00018	0.000999	CcSEcCtD
Losartan—Dermatitis—Vinorelbine—ovarian cancer	0.00018	0.000998	CcSEcCtD
Losartan—Hypotension—Paclitaxel—ovarian cancer	0.00018	0.000996	CcSEcCtD
Losartan—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00018	0.000996	CcSEcCtD
Losartan—Headache—Vinorelbine—ovarian cancer	0.000179	0.000992	CcSEcCtD
Losartan—Syncope—Docetaxel—ovarian cancer	0.000179	0.000992	CcSEcCtD
Losartan—Influenza—Doxorubicin—ovarian cancer	0.000179	0.000991	CcSEcCtD
Losartan—Leukopenia—Docetaxel—ovarian cancer	0.000179	0.000991	CcSEcCtD
Losartan—Pollakiuria—Epirubicin—ovarian cancer	0.000179	0.00099	CcSEcCtD
Losartan—Eosinophilia—Doxorubicin—ovarian cancer	0.000177	0.000981	CcSEcCtD
Losartan—Palpitations—Docetaxel—ovarian cancer	0.000177	0.000978	CcSEcCtD
Losartan—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000177	0.000978	CcSEcCtD
Losartan—Weight increased—Epirubicin—ovarian cancer	0.000176	0.000975	CcSEcCtD
Losartan—Loss of consciousness—Docetaxel—ovarian cancer	0.000176	0.000973	CcSEcCtD
Losartan—Pancreatitis—Doxorubicin—ovarian cancer	0.000176	0.000972	CcSEcCtD
Losartan—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000175	0.000971	CcSEcCtD
Losartan—Hyperglycaemia—Epirubicin—ovarian cancer	0.000175	0.000966	CcSEcCtD
Losartan—Cough—Docetaxel—ovarian cancer	0.000174	0.000966	CcSEcCtD
Losartan—Angina pectoris—Doxorubicin—ovarian cancer	0.000174	0.000966	CcSEcCtD
Losartan—Insomnia—Paclitaxel—ovarian cancer	0.000174	0.000964	CcSEcCtD
Losartan—Pneumonia—Epirubicin—ovarian cancer	0.000174	0.000961	CcSEcCtD
Losartan—Paraesthesia—Paclitaxel—ovarian cancer	0.000173	0.000957	CcSEcCtD
Losartan—Bronchitis—Doxorubicin—ovarian cancer	0.000172	0.000953	CcSEcCtD
Losartan—Dyspnoea—Paclitaxel—ovarian cancer	0.000172	0.00095	CcSEcCtD
Losartan—Somnolence—Paclitaxel—ovarian cancer	0.000171	0.000947	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000171	0.000947	CcSEcCtD
Losartan—Myalgia—Docetaxel—ovarian cancer	0.00017	0.000942	CcSEcCtD
Losartan—Arthralgia—Docetaxel—ovarian cancer	0.00017	0.000942	CcSEcCtD
Losartan—Chest pain—Docetaxel—ovarian cancer	0.00017	0.000942	CcSEcCtD
Losartan—Nausea—Vinorelbine—ovarian cancer	0.00017	0.000941	CcSEcCtD
Losartan—Renal failure—Epirubicin—ovarian cancer	0.00017	0.000939	CcSEcCtD
Losartan—Dyspepsia—Paclitaxel—ovarian cancer	0.000169	0.000938	CcSEcCtD
Losartan—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000169	0.000936	CcSEcCtD
Losartan—Jaundice—Epirubicin—ovarian cancer	0.000168	0.000931	CcSEcCtD
Losartan—Conjunctivitis—Epirubicin—ovarian cancer	0.000168	0.000928	CcSEcCtD
Losartan—Urinary tract infection—Epirubicin—ovarian cancer	0.000168	0.000928	CcSEcCtD
Losartan—Decreased appetite—Paclitaxel—ovarian cancer	0.000167	0.000926	CcSEcCtD
Losartan—Dry mouth—Docetaxel—ovarian cancer	0.000166	0.000921	CcSEcCtD
Losartan—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000166	0.000921	CcSEcCtD
Losartan—Fatigue—Paclitaxel—ovarian cancer	0.000166	0.000919	CcSEcCtD
Losartan—Sweating—Epirubicin—ovarian cancer	0.000165	0.000916	CcSEcCtD
Losartan—Pollakiuria—Doxorubicin—ovarian cancer	0.000165	0.000916	CcSEcCtD
Losartan—Pain—Paclitaxel—ovarian cancer	0.000165	0.000911	CcSEcCtD
Losartan—Constipation—Paclitaxel—ovarian cancer	0.000165	0.000911	CcSEcCtD
Losartan—Confusional state—Docetaxel—ovarian cancer	0.000165	0.000911	CcSEcCtD
Losartan—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000163	0.000905	CcSEcCtD
Losartan—Oedema—Docetaxel—ovarian cancer	0.000163	0.000903	CcSEcCtD
Losartan—Anaphylactic shock—Docetaxel—ovarian cancer	0.000163	0.000903	CcSEcCtD
Losartan—Weight increased—Doxorubicin—ovarian cancer	0.000163	0.000902	CcSEcCtD
Losartan—Epistaxis—Epirubicin—ovarian cancer	0.000163	0.000901	CcSEcCtD
Losartan—Infection—Docetaxel—ovarian cancer	0.000162	0.000897	CcSEcCtD
Losartan—Sinusitis—Epirubicin—ovarian cancer	0.000162	0.000896	CcSEcCtD
Losartan—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000162	0.000894	CcSEcCtD
Losartan—Agranulocytosis—Epirubicin—ovarian cancer	0.000161	0.000891	CcSEcCtD
Losartan—Pneumonia—Doxorubicin—ovarian cancer	0.000161	0.000889	CcSEcCtD
Losartan—Shock—Docetaxel—ovarian cancer	0.000161	0.000889	CcSEcCtD
Losartan—Nervous system disorder—Docetaxel—ovarian cancer	0.00016	0.000886	CcSEcCtD
Losartan—Thrombocytopenia—Docetaxel—ovarian cancer	0.00016	0.000884	CcSEcCtD
Losartan—Tachycardia—Docetaxel—ovarian cancer	0.000159	0.000881	CcSEcCtD
Losartan—Feeling abnormal—Paclitaxel—ovarian cancer	0.000159	0.000878	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000158	0.000876	CcSEcCtD
Losartan—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000157	0.000871	CcSEcCtD
Losartan—Renal failure—Doxorubicin—ovarian cancer	0.000157	0.000869	CcSEcCtD
Losartan—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000157	0.000866	CcSEcCtD
Losartan—Jaundice—Doxorubicin—ovarian cancer	0.000156	0.000861	CcSEcCtD
Losartan—Anorexia—Docetaxel—ovarian cancer	0.000156	0.000861	CcSEcCtD
Losartan—Rhinitis—Epirubicin—ovarian cancer	0.000155	0.00086	CcSEcCtD
Losartan—Conjunctivitis—Doxorubicin—ovarian cancer	0.000155	0.000859	CcSEcCtD
Losartan—Urinary tract infection—Doxorubicin—ovarian cancer	0.000155	0.000859	CcSEcCtD
Losartan—Hepatitis—Epirubicin—ovarian cancer	0.000155	0.000857	CcSEcCtD
Losartan—Hypoaesthesia—Epirubicin—ovarian cancer	0.000154	0.000853	CcSEcCtD
Losartan—Pharyngitis—Epirubicin—ovarian cancer	0.000154	0.000851	CcSEcCtD
Losartan—Sweating—Doxorubicin—ovarian cancer	0.000153	0.000847	CcSEcCtD
Losartan—Urticaria—Paclitaxel—ovarian cancer	0.000153	0.000847	CcSEcCtD
Losartan—Hypotension—Docetaxel—ovarian cancer	0.000152	0.000844	CcSEcCtD
Losartan—Abdominal pain—Paclitaxel—ovarian cancer	0.000152	0.000842	CcSEcCtD
Losartan—Body temperature increased—Paclitaxel—ovarian cancer	0.000152	0.000842	CcSEcCtD
Losartan—Epistaxis—Doxorubicin—ovarian cancer	0.000151	0.000834	CcSEcCtD
Losartan—Sinusitis—Doxorubicin—ovarian cancer	0.00015	0.000829	CcSEcCtD
Losartan—ABCB1—lymph node—ovarian cancer	0.00015	0.00244	CbGeAlD
Losartan—Agranulocytosis—Doxorubicin—ovarian cancer	0.000149	0.000825	CcSEcCtD
Losartan—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000149	0.000823	CcSEcCtD
Losartan—Insomnia—Docetaxel—ovarian cancer	0.000148	0.000817	CcSEcCtD
Losartan—Paraesthesia—Docetaxel—ovarian cancer	0.000147	0.000811	CcSEcCtD
Losartan—Erythema multiforme—Epirubicin—ovarian cancer	0.000146	0.000811	CcSEcCtD
Losartan—Dyspnoea—Docetaxel—ovarian cancer	0.000145	0.000805	CcSEcCtD
Losartan—Somnolence—Docetaxel—ovarian cancer	0.000145	0.000803	CcSEcCtD
Losartan—Tinnitus—Epirubicin—ovarian cancer	0.000144	0.000799	CcSEcCtD
Losartan—Flushing—Epirubicin—ovarian cancer	0.000144	0.000796	CcSEcCtD
Losartan—Rhinitis—Doxorubicin—ovarian cancer	0.000144	0.000795	CcSEcCtD
Losartan—Dyspepsia—Docetaxel—ovarian cancer	0.000144	0.000795	CcSEcCtD
Losartan—Hepatitis—Doxorubicin—ovarian cancer	0.000143	0.000793	CcSEcCtD
Losartan—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000143	0.000789	CcSEcCtD
Losartan—Pharyngitis—Doxorubicin—ovarian cancer	0.000142	0.000787	CcSEcCtD
Losartan—Decreased appetite—Docetaxel—ovarian cancer	0.000142	0.000785	CcSEcCtD
Losartan—Hypersensitivity—Paclitaxel—ovarian cancer	0.000142	0.000785	CcSEcCtD
Losartan—Fatigue—Docetaxel—ovarian cancer	0.000141	0.000779	CcSEcCtD
Losartan—Angiopathy—Epirubicin—ovarian cancer	0.000141	0.000778	CcSEcCtD
Losartan—Pain—Docetaxel—ovarian cancer	0.00014	0.000772	CcSEcCtD
Losartan—Constipation—Docetaxel—ovarian cancer	0.00014	0.000772	CcSEcCtD
Losartan—Arrhythmia—Epirubicin—ovarian cancer	0.000138	0.000766	CcSEcCtD
Losartan—Asthenia—Paclitaxel—ovarian cancer	0.000138	0.000765	CcSEcCtD
Losartan—Alopecia—Epirubicin—ovarian cancer	0.000137	0.000758	CcSEcCtD
Losartan—Pruritus—Paclitaxel—ovarian cancer	0.000136	0.000754	CcSEcCtD
Losartan—Erythema multiforme—Doxorubicin—ovarian cancer	0.000136	0.00075	CcSEcCtD
Losartan—Erythema—Epirubicin—ovarian cancer	0.000135	0.000746	CcSEcCtD
Losartan—Feeling abnormal—Docetaxel—ovarian cancer	0.000134	0.000744	CcSEcCtD
Losartan—Tinnitus—Doxorubicin—ovarian cancer	0.000134	0.00074	CcSEcCtD
Losartan—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000133	0.000739	CcSEcCtD
Losartan—Flushing—Doxorubicin—ovarian cancer	0.000133	0.000736	CcSEcCtD
Losartan—Flatulence—Epirubicin—ovarian cancer	0.000133	0.000736	CcSEcCtD
Losartan—Tension—Epirubicin—ovarian cancer	0.000132	0.000732	CcSEcCtD
Losartan—Dysgeusia—Epirubicin—ovarian cancer	0.000132	0.000731	CcSEcCtD
Losartan—Diarrhoea—Paclitaxel—ovarian cancer	0.000132	0.000729	CcSEcCtD
Losartan—Nervousness—Epirubicin—ovarian cancer	0.000131	0.000725	CcSEcCtD
Losartan—Back pain—Epirubicin—ovarian cancer	0.00013	0.000722	CcSEcCtD
Losartan—Angiopathy—Doxorubicin—ovarian cancer	0.00013	0.00072	CcSEcCtD
Losartan—Muscle spasms—Epirubicin—ovarian cancer	0.00013	0.000718	CcSEcCtD
Losartan—Abdominal pain—Docetaxel—ovarian cancer	0.000129	0.000714	CcSEcCtD
Losartan—Body temperature increased—Docetaxel—ovarian cancer	0.000129	0.000714	CcSEcCtD
Losartan—Arrhythmia—Doxorubicin—ovarian cancer	0.000128	0.000709	CcSEcCtD
Losartan—Dizziness—Paclitaxel—ovarian cancer	0.000127	0.000705	CcSEcCtD
Losartan—Vision blurred—Epirubicin—ovarian cancer	0.000127	0.000703	CcSEcCtD
Losartan—Alopecia—Doxorubicin—ovarian cancer	0.000127	0.000701	CcSEcCtD
Losartan—Ill-defined disorder—Epirubicin—ovarian cancer	0.000125	0.000693	CcSEcCtD
Losartan—Erythema—Doxorubicin—ovarian cancer	0.000125	0.000691	CcSEcCtD
Losartan—Anaemia—Epirubicin—ovarian cancer	0.000125	0.00069	CcSEcCtD
Losartan—Agitation—Epirubicin—ovarian cancer	0.000124	0.000686	CcSEcCtD
Losartan—Flatulence—Doxorubicin—ovarian cancer	0.000123	0.000681	CcSEcCtD
Losartan—Tension—Doxorubicin—ovarian cancer	0.000122	0.000678	CcSEcCtD
Losartan—Vomiting—Paclitaxel—ovarian cancer	0.000122	0.000678	CcSEcCtD
Losartan—Dysgeusia—Doxorubicin—ovarian cancer	0.000122	0.000676	CcSEcCtD
Losartan—Malaise—Epirubicin—ovarian cancer	0.000122	0.000673	CcSEcCtD
Losartan—Rash—Paclitaxel—ovarian cancer	0.000121	0.000672	CcSEcCtD
Losartan—Dermatitis—Paclitaxel—ovarian cancer	0.000121	0.000671	CcSEcCtD
Losartan—Nervousness—Doxorubicin—ovarian cancer	0.000121	0.000671	CcSEcCtD
Losartan—Vertigo—Epirubicin—ovarian cancer	0.000121	0.000671	CcSEcCtD
Losartan—Syncope—Epirubicin—ovarian cancer	0.000121	0.000669	CcSEcCtD
Losartan—Leukopenia—Epirubicin—ovarian cancer	0.000121	0.000668	CcSEcCtD
Losartan—Back pain—Doxorubicin—ovarian cancer	0.000121	0.000668	CcSEcCtD
Losartan—Headache—Paclitaxel—ovarian cancer	0.000121	0.000668	CcSEcCtD
Losartan—Hypersensitivity—Docetaxel—ovarian cancer	0.00012	0.000665	CcSEcCtD
Losartan—Muscle spasms—Doxorubicin—ovarian cancer	0.00012	0.000664	CcSEcCtD
Losartan—Palpitations—Epirubicin—ovarian cancer	0.000119	0.00066	CcSEcCtD
Losartan—Loss of consciousness—Epirubicin—ovarian cancer	0.000119	0.000656	CcSEcCtD
Losartan—Cough—Epirubicin—ovarian cancer	0.000118	0.000651	CcSEcCtD
Losartan—Vision blurred—Doxorubicin—ovarian cancer	0.000118	0.000651	CcSEcCtD
Losartan—Asthenia—Docetaxel—ovarian cancer	0.000117	0.000648	CcSEcCtD
Losartan—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000116	0.000641	CcSEcCtD
Losartan—Pruritus—Docetaxel—ovarian cancer	0.000115	0.000639	CcSEcCtD
Losartan—Anaemia—Doxorubicin—ovarian cancer	0.000115	0.000638	CcSEcCtD
Losartan—Myalgia—Epirubicin—ovarian cancer	0.000115	0.000635	CcSEcCtD
Losartan—Arthralgia—Epirubicin—ovarian cancer	0.000115	0.000635	CcSEcCtD
Losartan—Chest pain—Epirubicin—ovarian cancer	0.000115	0.000635	CcSEcCtD
Losartan—Agitation—Doxorubicin—ovarian cancer	0.000115	0.000635	CcSEcCtD
Losartan—Anxiety—Epirubicin—ovarian cancer	0.000114	0.000633	CcSEcCtD
Losartan—Nausea—Paclitaxel—ovarian cancer	0.000114	0.000633	CcSEcCtD
Losartan—Discomfort—Epirubicin—ovarian cancer	0.000113	0.000628	CcSEcCtD
Losartan—Malaise—Doxorubicin—ovarian cancer	0.000113	0.000623	CcSEcCtD
Losartan—Dry mouth—Epirubicin—ovarian cancer	0.000112	0.000622	CcSEcCtD
Losartan—Vertigo—Doxorubicin—ovarian cancer	0.000112	0.000621	CcSEcCtD
Losartan—Syncope—Doxorubicin—ovarian cancer	0.000112	0.000619	CcSEcCtD
Losartan—Leukopenia—Doxorubicin—ovarian cancer	0.000112	0.000618	CcSEcCtD
Losartan—Diarrhoea—Docetaxel—ovarian cancer	0.000112	0.000618	CcSEcCtD
Losartan—Confusional state—Epirubicin—ovarian cancer	0.000111	0.000614	CcSEcCtD
Losartan—Palpitations—Doxorubicin—ovarian cancer	0.00011	0.00061	CcSEcCtD
Losartan—Anaphylactic shock—Epirubicin—ovarian cancer	0.00011	0.000609	CcSEcCtD
Losartan—Oedema—Epirubicin—ovarian cancer	0.00011	0.000609	CcSEcCtD
Losartan—Loss of consciousness—Doxorubicin—ovarian cancer	0.00011	0.000607	CcSEcCtD
Losartan—Infection—Epirubicin—ovarian cancer	0.000109	0.000605	CcSEcCtD
Losartan—Cough—Doxorubicin—ovarian cancer	0.000109	0.000603	CcSEcCtD
Losartan—Shock—Epirubicin—ovarian cancer	0.000108	0.000599	CcSEcCtD
Losartan—Nervous system disorder—Epirubicin—ovarian cancer	0.000108	0.000597	CcSEcCtD
Losartan—Dizziness—Docetaxel—ovarian cancer	0.000108	0.000597	CcSEcCtD
Losartan—Thrombocytopenia—Epirubicin—ovarian cancer	0.000108	0.000596	CcSEcCtD
Losartan—Tachycardia—Epirubicin—ovarian cancer	0.000107	0.000595	CcSEcCtD
Losartan—Hyperhidrosis—Epirubicin—ovarian cancer	0.000106	0.000589	CcSEcCtD
Losartan—Chest pain—Doxorubicin—ovarian cancer	0.000106	0.000588	CcSEcCtD
Losartan—Arthralgia—Doxorubicin—ovarian cancer	0.000106	0.000588	CcSEcCtD
Losartan—Myalgia—Doxorubicin—ovarian cancer	0.000106	0.000588	CcSEcCtD
Losartan—Anxiety—Doxorubicin—ovarian cancer	0.000106	0.000586	CcSEcCtD
Losartan—Discomfort—Doxorubicin—ovarian cancer	0.000105	0.000581	CcSEcCtD
Losartan—Anorexia—Epirubicin—ovarian cancer	0.000105	0.000581	CcSEcCtD
Losartan—Telmisartan—ABCB1—ovarian cancer	0.000105	0.554	CrCbGaD
Losartan—Dry mouth—Doxorubicin—ovarian cancer	0.000104	0.000575	CcSEcCtD
Losartan—Vomiting—Docetaxel—ovarian cancer	0.000104	0.000574	CcSEcCtD
Losartan—Rash—Docetaxel—ovarian cancer	0.000103	0.000569	CcSEcCtD
Losartan—Hypotension—Epirubicin—ovarian cancer	0.000103	0.000569	CcSEcCtD
Losartan—Dermatitis—Docetaxel—ovarian cancer	0.000103	0.000569	CcSEcCtD
Losartan—Confusional state—Doxorubicin—ovarian cancer	0.000103	0.000568	CcSEcCtD
Losartan—Headache—Docetaxel—ovarian cancer	0.000102	0.000566	CcSEcCtD
Losartan—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000102	0.000564	CcSEcCtD
Losartan—Oedema—Doxorubicin—ovarian cancer	0.000102	0.000564	CcSEcCtD
Losartan—Infection—Doxorubicin—ovarian cancer	0.000101	0.00056	CcSEcCtD
Losartan—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.0001	0.000555	CcSEcCtD
Losartan—Shock—Doxorubicin—ovarian cancer	0.0001	0.000555	CcSEcCtD
Losartan—Nervous system disorder—Doxorubicin—ovarian cancer	9.99e-05	0.000553	CcSEcCtD
Losartan—Thrombocytopenia—Doxorubicin—ovarian cancer	9.97e-05	0.000552	CcSEcCtD
Losartan—Insomnia—Epirubicin—ovarian cancer	9.96e-05	0.000551	CcSEcCtD
Losartan—Tachycardia—Doxorubicin—ovarian cancer	9.94e-05	0.00055	CcSEcCtD
Losartan—Paraesthesia—Epirubicin—ovarian cancer	9.88e-05	0.000547	CcSEcCtD
Losartan—Hyperhidrosis—Doxorubicin—ovarian cancer	9.85e-05	0.000545	CcSEcCtD
Losartan—Dyspnoea—Epirubicin—ovarian cancer	9.81e-05	0.000543	CcSEcCtD
Losartan—Somnolence—Epirubicin—ovarian cancer	9.79e-05	0.000542	CcSEcCtD
Losartan—Anorexia—Doxorubicin—ovarian cancer	9.71e-05	0.000537	CcSEcCtD
Losartan—Nausea—Docetaxel—ovarian cancer	9.69e-05	0.000536	CcSEcCtD
Losartan—Dyspepsia—Epirubicin—ovarian cancer	9.69e-05	0.000536	CcSEcCtD
Losartan—Decreased appetite—Epirubicin—ovarian cancer	9.57e-05	0.00053	CcSEcCtD
Losartan—Hypotension—Doxorubicin—ovarian cancer	9.52e-05	0.000527	CcSEcCtD
Losartan—Fatigue—Epirubicin—ovarian cancer	9.49e-05	0.000525	CcSEcCtD
Losartan—Pain—Epirubicin—ovarian cancer	9.41e-05	0.000521	CcSEcCtD
Losartan—Constipation—Epirubicin—ovarian cancer	9.41e-05	0.000521	CcSEcCtD
Losartan—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	9.28e-05	0.000514	CcSEcCtD
Losartan—Insomnia—Doxorubicin—ovarian cancer	9.21e-05	0.00051	CcSEcCtD
Losartan—Paraesthesia—Doxorubicin—ovarian cancer	9.15e-05	0.000506	CcSEcCtD
Losartan—Dyspnoea—Doxorubicin—ovarian cancer	9.08e-05	0.000503	CcSEcCtD
Losartan—Feeling abnormal—Epirubicin—ovarian cancer	9.07e-05	0.000502	CcSEcCtD
Losartan—Somnolence—Doxorubicin—ovarian cancer	9.05e-05	0.000501	CcSEcCtD
Losartan—Gastrointestinal pain—Epirubicin—ovarian cancer	9e-05	0.000498	CcSEcCtD
Losartan—Dyspepsia—Doxorubicin—ovarian cancer	8.97e-05	0.000496	CcSEcCtD
Losartan—Decreased appetite—Doxorubicin—ovarian cancer	8.85e-05	0.00049	CcSEcCtD
Losartan—Fatigue—Doxorubicin—ovarian cancer	8.78e-05	0.000486	CcSEcCtD
Losartan—Urticaria—Epirubicin—ovarian cancer	8.74e-05	0.000484	CcSEcCtD
Losartan—Constipation—Doxorubicin—ovarian cancer	8.71e-05	0.000482	CcSEcCtD
Losartan—Pain—Doxorubicin—ovarian cancer	8.71e-05	0.000482	CcSEcCtD
Losartan—Body temperature increased—Epirubicin—ovarian cancer	8.7e-05	0.000482	CcSEcCtD
Losartan—Abdominal pain—Epirubicin—ovarian cancer	8.7e-05	0.000482	CcSEcCtD
Losartan—Candesartan—ABCB1—ovarian cancer	8.44e-05	0.446	CrCbGaD
Losartan—Feeling abnormal—Doxorubicin—ovarian cancer	8.39e-05	0.000465	CcSEcCtD
Losartan—Gastrointestinal pain—Doxorubicin—ovarian cancer	8.33e-05	0.000461	CcSEcCtD
Losartan—Hypersensitivity—Epirubicin—ovarian cancer	8.11e-05	0.000449	CcSEcCtD
Losartan—Urticaria—Doxorubicin—ovarian cancer	8.09e-05	0.000448	CcSEcCtD
Losartan—Body temperature increased—Doxorubicin—ovarian cancer	8.05e-05	0.000446	CcSEcCtD
Losartan—Abdominal pain—Doxorubicin—ovarian cancer	8.05e-05	0.000446	CcSEcCtD
Losartan—Asthenia—Epirubicin—ovarian cancer	7.9e-05	0.000437	CcSEcCtD
Losartan—Pruritus—Epirubicin—ovarian cancer	7.79e-05	0.000431	CcSEcCtD
Losartan—Diarrhoea—Epirubicin—ovarian cancer	7.53e-05	0.000417	CcSEcCtD
Losartan—Hypersensitivity—Doxorubicin—ovarian cancer	7.5e-05	0.000415	CcSEcCtD
Losartan—Asthenia—Doxorubicin—ovarian cancer	7.31e-05	0.000404	CcSEcCtD
Losartan—Dizziness—Epirubicin—ovarian cancer	7.28e-05	0.000403	CcSEcCtD
Losartan—Pruritus—Doxorubicin—ovarian cancer	7.21e-05	0.000399	CcSEcCtD
Losartan—Vomiting—Epirubicin—ovarian cancer	7e-05	0.000387	CcSEcCtD
Losartan—Diarrhoea—Doxorubicin—ovarian cancer	6.97e-05	0.000386	CcSEcCtD
Losartan—Rash—Epirubicin—ovarian cancer	6.94e-05	0.000384	CcSEcCtD
Losartan—Dermatitis—Epirubicin—ovarian cancer	6.93e-05	0.000384	CcSEcCtD
Losartan—Headache—Epirubicin—ovarian cancer	6.9e-05	0.000382	CcSEcCtD
Losartan—Dizziness—Doxorubicin—ovarian cancer	6.73e-05	0.000373	CcSEcCtD
Losartan—Nausea—Epirubicin—ovarian cancer	6.54e-05	0.000362	CcSEcCtD
Losartan—Vomiting—Doxorubicin—ovarian cancer	6.48e-05	0.000358	CcSEcCtD
Losartan—Rash—Doxorubicin—ovarian cancer	6.42e-05	0.000355	CcSEcCtD
Losartan—Dermatitis—Doxorubicin—ovarian cancer	6.42e-05	0.000355	CcSEcCtD
Losartan—Headache—Doxorubicin—ovarian cancer	6.38e-05	0.000353	CcSEcCtD
Losartan—Nausea—Doxorubicin—ovarian cancer	6.05e-05	0.000335	CcSEcCtD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.33e-05	0.000252	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6ST—ovarian cancer	1.33e-05	0.000252	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.33e-05	0.000252	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CAV1—ovarian cancer	1.32e-05	0.00025	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.32e-05	0.00025	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.3e-05	0.000246	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.3e-05	0.000246	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—APC—ovarian cancer	1.28e-05	0.000242	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CG—ovarian cancer	1.28e-05	0.000242	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—NRAS—ovarian cancer	1.28e-05	0.000242	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.27e-05	0.000241	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CG—ovarian cancer	1.27e-05	0.000239	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.26e-05	0.000239	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CD—ovarian cancer	1.25e-05	0.000236	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ABCB1—ovarian cancer	1.25e-05	0.000236	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.23e-05	0.000232	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—MAPK3—ovarian cancer	1.23e-05	0.000232	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—TYMS—ovarian cancer	1.22e-05	0.000231	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.21e-05	0.00023	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.21e-05	0.00023	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CG—ovarian cancer	1.21e-05	0.000228	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	1.17e-05	0.000222	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—YAP1—ovarian cancer	1.17e-05	0.000221	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—MAPK1—ovarian cancer	1.17e-05	0.000221	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—EGFR—ovarian cancer	1.17e-05	0.000221	CbGpPWpGaD
Losartan—ALB—Metabolism—YAP1—ovarian cancer	1.16e-05	0.00022	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.16e-05	0.000219	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.15e-05	0.000218	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.15e-05	0.000217	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.14e-05	0.000215	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.13e-05	0.000214	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CD—ovarian cancer	1.13e-05	0.000213	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—PIK3CA—ovarian cancer	1.12e-05	0.000211	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CD—ovarian cancer	1.11e-05	0.00021	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—KRAS—ovarian cancer	1.1e-05	0.000208	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—FASN—ovarian cancer	1.1e-05	0.000208	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.09e-05	0.000207	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CB—ovarian cancer	1.09e-05	0.000206	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.08e-05	0.000205	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CAV1—ovarian cancer	1.08e-05	0.000203	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYTB—ovarian cancer	1.07e-05	0.000203	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CD—ovarian cancer	1.06e-05	0.0002	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.05e-05	0.000198	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—YAP1—ovarian cancer	1.04e-05	0.000198	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.04e-05	0.000196	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.03e-05	0.000196	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	1.02e-05	0.000194	CbGpPWpGaD
Losartan—ABCB1—Metabolism—YAP1—ovarian cancer	1.02e-05	0.000193	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.02e-05	0.000193	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.01e-05	0.000192	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—PIK3CA—ovarian cancer	1.01e-05	0.000192	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1e-05	0.00019	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ERBB2—ovarian cancer	9.94e-06	0.000188	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CAV1—ovarian cancer	9.86e-06	0.000186	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MTOR—ovarian cancer	9.81e-06	0.000186	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CB—ovarian cancer	9.81e-06	0.000186	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CG—ovarian cancer	9.8e-06	0.000185	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CB—ovarian cancer	9.69e-06	0.000183	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—FASN—ovarian cancer	9.54e-06	0.00018	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—YAP1—ovarian cancer	9.53e-06	0.00018	CbGpPWpGaD
Losartan—ALB—Metabolism—FASN—ovarian cancer	9.49e-06	0.000179	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL8—ovarian cancer	9.43e-06	0.000178	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.43e-06	0.000178	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.42e-06	0.000178	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTEN—ovarian cancer	9.39e-06	0.000178	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC5A5—ovarian cancer	9.39e-06	0.000178	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HRAS—ovarian cancer	9.37e-06	0.000177	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPP1CC—ovarian cancer	9.37e-06	0.000177	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—BRIP1—ovarian cancer	9.37e-06	0.000177	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	9.37e-06	0.000177	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC5A5—ovarian cancer	9.33e-06	0.000177	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CB—ovarian cancer	9.24e-06	0.000175	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	9.22e-06	0.000174	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDKN1B—ovarian cancer	9.21e-06	0.000174	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AKT1—ovarian cancer	9.11e-06	0.000172	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.09e-06	0.000172	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC2A1—ovarian cancer	9.07e-06	0.000171	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CASP3—ovarian cancer	9.02e-06	0.000171	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC2A1—ovarian cancer	9.01e-06	0.00017	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL2—ovarian cancer	9.01e-06	0.00017	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	8.98e-06	0.00017	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL6—ovarian cancer	8.97e-06	0.00017	CbGpPWpGaD
Losartan—ALB—Hemostasis—IL2—ovarian cancer	8.9e-06	0.000168	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	8.9e-06	0.000168	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.88e-06	0.000168	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTEN—ovarian cancer	8.85e-06	0.000167	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.85e-06	0.000167	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.83e-06	0.000167	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCND1—ovarian cancer	8.78e-06	0.000166	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CTNNB1—ovarian cancer	8.7e-06	0.000165	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP1B1—ovarian cancer	8.69e-06	0.000164	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP1B1—ovarian cancer	8.64e-06	0.000163	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CD—ovarian cancer	8.61e-06	0.000163	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MMP9—ovarian cancer	8.53e-06	0.000161	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—FASN—ovarian cancer	8.52e-06	0.000161	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PTEN—ovarian cancer	8.48e-06	0.00016	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC5A5—ovarian cancer	8.38e-06	0.000158	CbGpPWpGaD
Losartan—ABCB1—Metabolism—FASN—ovarian cancer	8.31e-06	0.000157	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.29e-06	0.000157	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AKT1—ovarian cancer	8.27e-06	0.000156	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ABCB1—ovarian cancer	8.26e-06	0.000156	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC5A5—ovarian cancer	8.18e-06	0.000155	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—YAP1—ovarian cancer	8.14e-06	0.000154	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—TYMS—ovarian cancer	8.12e-06	0.000153	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC2A1—ovarian cancer	8.09e-06	0.000153	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.06e-06	0.000152	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTEN—ovarian cancer	7.98e-06	0.000151	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.92e-06	0.00015	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC2A1—ovarian cancer	7.9e-06	0.000149	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	7.89e-06	0.000149	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—FASN—ovarian cancer	7.77e-06	0.000147	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP1B1—ovarian cancer	7.76e-06	0.000147	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	7.71e-06	0.000146	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.67e-06	0.000145	CbGpPWpGaD
Losartan—ALB—Metabolism—PPP2R1A—ovarian cancer	7.66e-06	0.000145	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—ovarian cancer	7.66e-06	0.000145	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC5A5—ovarian cancer	7.64e-06	0.000144	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.63e-06	0.000144	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STAT3—ovarian cancer	7.58e-06	0.000143	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP1B1—ovarian cancer	7.57e-06	0.000143	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—ovarian cancer	7.57e-06	0.000143	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NRAS—ovarian cancer	7.56e-06	0.000143	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CB—ovarian cancer	7.51e-06	0.000142	CbGpPWpGaD
Losartan—ALB—Hemostasis—NRAS—ovarian cancer	7.47e-06	0.000141	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC2A1—ovarian cancer	7.38e-06	0.00014	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK3—ovarian cancer	7.24e-06	0.000137	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.22e-06	0.000137	CbGpPWpGaD
Losartan—ALB—Hemostasis—MAPK3—ovarian cancer	7.16e-06	0.000135	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ABCB1—ovarian cancer	7.16e-06	0.000135	CbGpPWpGaD
Losartan—ALB—Metabolism—ABCB1—ovarian cancer	7.12e-06	0.000135	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.08e-06	0.000134	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP1B1—ovarian cancer	7.07e-06	0.000134	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—ovarian cancer	7.05e-06	0.000133	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TYMS—ovarian cancer	7.03e-06	0.000133	CbGpPWpGaD
Losartan—ALB—Metabolism—TYMS—ovarian cancer	6.99e-06	0.000132	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK1—ovarian cancer	6.89e-06	0.00013	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EGFR—ovarian cancer	6.89e-06	0.00013	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	6.88e-06	0.00013	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	6.88e-06	0.00013	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.85e-06	0.000129	CbGpPWpGaD
Losartan—ALB—Hemostasis—MAPK1—ovarian cancer	6.81e-06	0.000129	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPP2R1A—ovarian cancer	6.72e-06	0.000127	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—FASN—ovarian cancer	6.64e-06	0.000126	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CA—ovarian cancer	6.62e-06	0.000125	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CAV1—ovarian cancer	6.54e-06	0.000124	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC5A5—ovarian cancer	6.53e-06	0.000123	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KRAS—ovarian cancer	6.51e-06	0.000123	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTEN—ovarian cancer	6.49e-06	0.000123	CbGpPWpGaD
Losartan—ALB—Hemostasis—KRAS—ovarian cancer	6.43e-06	0.000122	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ABCB1—ovarian cancer	6.39e-06	0.000121	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC2A1—ovarian cancer	6.3e-06	0.000119	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—YAP1—ovarian cancer	6.28e-06	0.000119	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TYMS—ovarian cancer	6.27e-06	0.000119	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	6.27e-06	0.000119	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.24e-06	0.000118	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	6.24e-06	0.000118	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.17e-06	0.000117	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TYMS—ovarian cancer	6.12e-06	0.000116	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP1B1—ovarian cancer	6.04e-06	0.000114	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CA—ovarian cancer	5.98e-06	0.000113	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CG—ovarian cancer	5.96e-06	0.000113	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTEN—ovarian cancer	5.94e-06	0.000112	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CA—ovarian cancer	5.91e-06	0.000112	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ABCB1—ovarian cancer	5.82e-06	0.00011	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—ovarian cancer	5.79e-06	0.000109	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TYMS—ovarian cancer	5.72e-06	0.000108	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—ovarian cancer	5.72e-06	0.000108	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CAV1—ovarian cancer	5.66e-06	0.000107	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CA—ovarian cancer	5.63e-06	0.000107	CbGpPWpGaD
Losartan—ALB—Metabolism—CAV1—ovarian cancer	5.63e-06	0.000107	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRAS—ovarian cancer	5.53e-06	0.000105	CbGpPWpGaD
Losartan—ALB—Hemostasis—HRAS—ovarian cancer	5.47e-06	0.000103	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.41e-06	0.000102	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—ovarian cancer	5.41e-06	0.000102	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.38e-06	0.000102	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	5.36e-06	0.000101	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.33e-06	0.000101	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—ovarian cancer	5.3e-06	0.0001	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CD—ovarian cancer	5.24e-06	9.9e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CG—ovarian cancer	5.16e-06	9.76e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CG—ovarian cancer	5.13e-06	9.7e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—FASN—ovarian cancer	5.12e-06	9.69e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—ovarian cancer	5.1e-06	9.64e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CAV1—ovarian cancer	5.06e-06	9.56e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.04e-06	9.53e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ABCB1—ovarian cancer	4.98e-06	9.41e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CAV1—ovarian cancer	4.93e-06	9.33e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TYMS—ovarian cancer	4.89e-06	9.25e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—ovarian cancer	4.89e-06	9.24e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.87e-06	9.2e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.83e-06	9.14e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—ovarian cancer	4.83e-06	9.13e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.66e-06	8.82e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CAV1—ovarian cancer	4.61e-06	8.72e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CG—ovarian cancer	4.6e-06	8.71e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—ovarian cancer	4.6e-06	8.7e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CA—ovarian cancer	4.58e-06	8.66e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CB—ovarian cancer	4.56e-06	8.63e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CD—ovarian cancer	4.54e-06	8.58e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CD—ovarian cancer	4.51e-06	8.53e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.49e-06	8.5e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.4e-06	8.33e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CG—ovarian cancer	4.2e-06	7.94e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	4.19e-06	7.93e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.14e-06	7.83e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CD—ovarian cancer	4.05e-06	7.66e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.95e-06	7.48e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.95e-06	7.47e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTEN—ovarian cancer	3.94e-06	7.46e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CAV1—ovarian cancer	3.94e-06	7.45e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CB—ovarian cancer	3.93e-06	7.43e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.84e-06	7.27e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TYMS—ovarian cancer	3.77e-06	7.14e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.76e-06	7.12e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—ovarian cancer	3.74e-06	7.07e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.69e-06	6.98e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CG—ovarian cancer	3.59e-06	6.79e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CB—ovarian cancer	3.53e-06	6.67e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.44e-06	6.51e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—ovarian cancer	3.43e-06	6.48e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTEN—ovarian cancer	3.42e-06	6.46e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTEN—ovarian cancer	3.4e-06	6.42e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.22e-06	6.09e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CD—ovarian cancer	3.15e-06	5.97e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTEN—ovarian cancer	3.05e-06	5.77e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CAV1—ovarian cancer	3.04e-06	5.75e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTEN—ovarian cancer	2.98e-06	5.63e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.78e-06	5.26e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTEN—ovarian cancer	2.78e-06	5.26e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.77e-06	5.24e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.75e-06	5.2e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.43e-06	4.6e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.41e-06	4.56e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CA—ovarian cancer	2.4e-06	4.53e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTEN—ovarian cancer	2.38e-06	4.49e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—ovarian cancer	2.27e-06	4.3e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.15e-06	4.07e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.12e-06	4.01e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.1e-06	3.97e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—ovarian cancer	1.97e-06	3.72e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.96e-06	3.71e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—ovarian cancer	1.96e-06	3.7e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTEN—ovarian cancer	1.83e-06	3.47e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—ovarian cancer	1.76e-06	3.32e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—ovarian cancer	1.72e-06	3.24e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.68e-06	3.17e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—ovarian cancer	1.6e-06	3.03e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—ovarian cancer	1.37e-06	2.59e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.29e-06	2.45e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—ovarian cancer	1.06e-06	2e-05	CbGpPWpGaD
